Plasma calprotectin: A new prognostic marker of survival in alcohol-induced cirrhosis;Plasmacalprotektin: En ny prognostisk markør for overlevelse ved alkoholisk levercirrose

Ugeskrift for Laeger

Volumn 158, Issue 21, 1996, Pages 2980-2984

  Homann, Christian ^a   Garred, Peter ^a   Graudal, Niels A ^a   Hasselqvist, Philip ^a   Christiansen, Michael ^a   Fagerhol, Magne K ^a   Thomsen, Åge Chr ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CALGRANULIN; NERVE CELL ADHESION MOLECULE; PLASMA PROTEIN;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD; CLINICAL TRIAL; CROSSOVER PROCEDURE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY;

ADULT; AGED; ANTIFUNGAL AGENTS; BLOOD PROTEINS; CROSS-OVER STUDIES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0030594549     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986; 6: 252-62.
2. Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotektin (the L1 leukocyte protein). I: Vana L, Smith JR, Dedman JR, eds. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton, Fla.: CRS Press Inc. 1990: 187-210.
3. Fagerhol MK, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Europ Physiopathol Resp 1980; 16 (suppl): 273-81.
4. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte LI protein, calprotektin. Lancet 1990; 336: 763-5.
5. Wyke RJ. Problems of bacterial infection in patients with liver disease. Gut 1987; 28: 623-41.
6. Garred P, Fosse E, Fagerhol MK, Videm V, Mollnes TE. Calprotektin and complement activation during major operations with or without cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 694-9.
7. Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leukocyte L1 protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357-62.
8. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L, and the VA Cooperative Study Group. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991; 86: 210-6.
9. Tarao K, So K, Moroi T, Ikeuchi T, Suyama T, Endo O et al. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance. Gastroenterology 1977; 73: 539-42.
10. Gaeta GB, Perna P, Adinolfi LE, Ruggiero G. Endotoxemia in a series of 104 patients with chronic liver diseases: prevalence and significance. Digestion 1982; 23: 23944.
11. Bigatello LM, Broitman SA, Fattori L, Paoli MD, Pontello M, Bevilacqua G et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am J Gastroenterol 1987; 82: 11-5.
12. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987; 4: 8-14.
13. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991; 12: 162-9.
14. Morrison DC, Ulevitch RJ. The effect of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93: 527-617.
15. Belenko M, Chanana AD, Joel DD, Fagerhol MK, Janoff A. Tracing the leukocyte marker protein in lung fluids and lung-draining lymph nodes during endotoxemia in sheep. Am Rev Respir Dis 1986; 133: 866-74.
16. Van Zee KJ, Deforge LE, Fischer E, Marano MA, Kenney JS, Remick DG, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146: 3478-82.
17. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13: 267-76.
18. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-6.
19. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong H, Veech GA et al. Plasma tumor necrosis factor Ta T predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14: 255-9.
20. Bird GLA, Sheron N, Goka J, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112: 917-20.